ASX Filings

Opthea CEO Presentation of Trial Updates at OIS@AAO 2018

October 26, 2018

Opthea Reports Positive Data from Ph1b DME Study of OPT-302

October 26, 2018

Opthea To Present at the Ophthalmology Innovation Summit

October 24, 2018

Appendix 3B

October 22, 2018

Appendix 3B

October 15, 2018

Appendix 3B

September 28, 2018

Change in substantial holding

September 26, 2018

Opthea to Host wAMD and DME Key Opinion Leader Forum

September 24, 2018

Appendix 3B

September 20, 2018

Opthea Doses First Patients in Australia for Phase 2a in DME

September 17, 2018